These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 6832881)
1. Therapeutic effect of rifampicin and isoniazid against Leishmania tropica major. Livshin R; El-On J; Weinrauch L; Greenblatt CL; Even-Paz Z Int J Dermatol; 1983; 22(1):61. PubMed ID: 6832881 [No Abstract] [Full Text] [Related]
2. Efficacy of rifampicin and isoniazid in cutaneous leishmaniasis. Livshin R; Weinrauch L; Even-Paz Z; el-On J Int J Dermatol; 1987; 26(1):55-9. PubMed ID: 3557792 [TBL] [Abstract][Full Text] [Related]
3. Potentiating action of rifampicin and isoniazid against Leishmania mexicana amazonensis. Peters W; Lainson R; Shaw JJ; Robinson BL; Leão AF Lancet; 1981 May; 1(8230):1122-4. PubMed ID: 6112485 [TBL] [Abstract][Full Text] [Related]
4. Limited therapeutic action of rifampicin/isoniazid against Leishmania aethiopica. van der Meulen J; Mock B; Fekete E; Sarojini PA Lancet; 1981 Jul; 2(8239):197-8. PubMed ID: 6114258 [No Abstract] [Full Text] [Related]
5. Leishmaniasis: a case history and treatment failure with rifampin. White SW; Hendricks LD; Chulay JD Arch Dermatol; 1980 Jun; 116(6):620-1. PubMed ID: 7377797 [No Abstract] [Full Text] [Related]
7. [Cutaneous leishmaniasis: an autochtonous case in Switzerland?]. Mazzi R Dermatologica; 1976; 153(2):104-5. PubMed ID: 1001590 [TBL] [Abstract][Full Text] [Related]
8. Treatment of malaria tropica with a fixed combination of rifampicin, co-trimoxazole and isoniazid: a clinical study. Goerg H; Ochola SA; Goerg R Chemotherapy; 1999; 45(1):68-76. PubMed ID: 9876212 [TBL] [Abstract][Full Text] [Related]
9. The treatment of diffuse cutaneous leishmaniasis: a report of two cases. Okelo GB; Sang D; Bhatt KM East Afr Med J; 1991 Jan; 68(1):67-8. PubMed ID: 1647944 [No Abstract] [Full Text] [Related]
10. [Comparative studies on therapeutic effect of rifampicin and isoniazid on experimental mouse tuberculosis (author's transl)]. Kondo E; Kanai K Kekkaku; 1978 Apr; 53(4):261-4. PubMed ID: 661058 [No Abstract] [Full Text] [Related]
12. [Comparative therapeutic activity of rifampicin and isoniazid in different densities of microbial population in the lungs of experimental animals]. Sodikov ES; Ismatullaev F Probl Tuberk; 1986; (6):50-3. PubMed ID: 3092209 [No Abstract] [Full Text] [Related]
13. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients]. Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895 [No Abstract] [Full Text] [Related]
15. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide]. Chioléro R Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521 [No Abstract] [Full Text] [Related]